aminacrine has been researched along with ATLL in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ju, W; Maeda, M; Petrus, M; Pise-Masison, CA; Waldmann, TA; Zhang, M | 1 |
| Barnett, FB; Epenetos, AA; Griffin, MM; Steven, FS | 1 |
2 other study(ies) available for aminacrine and ATLL
| Article | Year |
|---|---|
Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia.
Topics: Alemtuzumab; Aminacrine; Animals; Antibodies, Monoclonal, Humanized; Caspase 3; Caspase 7; Cell Line, Tumor; Disease Models, Animal; Humans; Interleukin-2 Receptor alpha Subunit; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; T-Lymphocytes; Transcription, Genetic; Tumor Suppressor Protein p53 | 2014 |
Competitive inhibition of a tumour cell surface protease. A rapid technique for in vitro testing of selective targeting systems.
Topics: Agmatine; Aminacrine; Animals; Binding Sites; Binding, Competitive; Biomarkers, Tumor; Carboxylic Ester Hydrolases; Cell Membrane; Drug Carriers; Endopeptidases; Kidney Neoplasms; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Experimental; Mitomycin; Mitomycins; Protease Inhibitors; Rats; Succinates | 1990 |